OtherHot Topics
Open Access
Oligometastatic prostate cancer: molecular imaging and clinical management implications in the era of precision oncology
Hossein Jadvar
Journal of Nuclear Medicine July 2018, jnumed.118.213470; DOI: https://doi.org/10.2967/jnumed.118.213470
Hossein Jadvar
University of Southern California, United States
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Oligometastatic prostate cancer: molecular imaging and clinical management implications in the era of precision oncology
Hossein Jadvar
Journal of Nuclear Medicine Jul 2018, jnumed.118.213470; DOI: 10.2967/jnumed.118.213470
Jump to section
Related Articles
Cited By...
- Oligometastatic Prostate Cancer: Current Status and Future Challenges
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
- A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer